NOMINAL CONTRIBUTION OF LOW AND LOWER-MIDDLE- INCOME COUNTRIES (LMICs) IN MAJOR CLINICAL TRIALS ON SECONDARY STROKE PREVENTION: IMPLICATIONS FOR GUIDELINE DEVELOPMENT

Approximately 90% of all stroke deaths and disabilities occur in LMICs where implementation of secondary prevention is constrained. Clinicians in LMIC settings depend on stroke guidelines emanating from high-income countries developed largely using clinical trial data with minimal contribution of study participants from LMICs.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research